NICE Major Changes to Type 2 Diabetes Care: What This Means for Kidney Health
- News Team | African Caribbean Kidney Education Enterprise
- Feb 19
- 3 min read
The National Institute for Health and Care Excellence, NICE, has now published final guidance introducing major changes to Type 2 diabetes treatment in England.
These updated recommendations place stronger emphasis on protecting long term heart and kidney health, and not just on lowering blood glucose levels.
For organisations focused on preventing kidney disease and promoting kidney health, this is a significant development.
What has changed?
NICE now recommends earlier use of SGLT-2 inhibitors for many people living with Type 2 diabetes. In some cases, these medicines may be offered alongside Metformin, a commonly prescribed first line treatment for Type 2 diabetes, rather than being introduced later in the treatment pathway.
Although originally used to manage blood glucose, strong clinical evidence shows that SGLT-2 inhibitors can also:
Slow the progression of chronic kidney disease
Reduce the risk of heart failure
Lower the risk of serious cardiovascular events
This means that earlier use may provide earlier protection.
Why this matters for kidney health
Type 2 diabetes remains one of the leading causes of chronic kidney disease in the United Kingdom.
Kidney damage often develops gradually and without symptoms. Many people are unaware there is a problem until their kidney function has already declined significantly.
Access to medicines that protect kidney function at an earlier stage could:
Slow down kidney decline
Reduce the number of people progressing to dialysis
Lower the need for kidney transplantation
Improve long term quality of life
This change in guidance is therefore relevant not only to diabetes care, but also to kidney disease prevention.
What this means for patients
If you are living with Type 2 diabetes, or supporting someone who is, you may wish to speak with your GP or diabetes team about:
Whether SGLT-2 inhibitors are suitable for you
Your most recent kidney function results
How often your kidney function is being monitored
Treatment decisions are always individual and depend on personal circumstances. However, the updated guidance broadens access to medicines that have proven kidney benefits.
Equity and access still matter
When the proposed changes were first announced, we raised important questions about equitable access, particularly for Black communities who are disproportionately affected by kidney disease and Type 2 diabetes.
NICE’s earlier analysis highlighted that SGLT-2 inhibitors were under prescribed to Black patients, women, and older people. Given that people of African and Caribbean heritage are up to five times more likely to develop kidney disease, ensuring fair access to protective treatment is essential.
As this guidance moves from announcement to implementation, those concerns remain relevant.
From guidance to impact
This updated guidance has the potential to reduce heart attacks, slow kidney decline, and prevent many people from progressing to kidney failure.
But guidance alone does not change outcomes.
Access, awareness, and fair implementation will determine who benefits. Communities already at higher risk of kidney disease must not be overlooked as these changes are rolled out.
Here at the African Caribbean Kidney Education Enterprise® (ACKEE) , we welcome this shift in Type 2 diabetes care. Earlier kidney protection is a positive step.
However, we continue to call on NICE, the NHS, and wider partners to work directly with communities most affected, ensuring that eligibility translates into actual access.
Progress only matters if it benefits us all.
How you can support ACKEE:
Share – Spread this blog and ACKEE’s work to raise awareness about kidney health and medication access.
Donate – ACKEE’s work is only possible thanks to supporters like you. Kidney disease disproportionately affects the African Caribbean community, and many still lack access to information and support. Make a donation today. Your generous support helps ACKEE provide education and resources to the African Caribbean community
Comments